Skip to main navigation Skip to search Skip to main content

Epstein-Barr virus seroreactivity among unaffected individuals within high-risk nasopharyngeal carcinoma families in Taiwan

  • Amy Pickard
  • , Chien Jen Chen
  • , Scott R. Diehl
  • , Mei Ying Liu
  • , Yu Juen Cheng
  • , Wan Lun Hsu
  • , Brenda Sun
  • , Mow Ming Hsu
  • , I. How Chen
  • , Jen Yang Chen
  • , Czau Siung Yang
  • , Beth L. Mittl
  • , Sheng Ping Chou
  • , Deborah D. Ruggles
  • , Alisa M. Goldstein
  • , Allan Hildesheim*
  • *Corresponding author for this work
  • National Institutes of Health
  • National Taiwan University
  • Rutgers - The State University of New Jersey, Newark
  • National Taipei University of Nursing and Health Sciences
  • Westat
  • Chang Gung Memorial Hospital
  • National Health Research Institutes Taiwan

Research output: Contribution to journalJournal Article peer-review

54 Scopus citations

Abstract

Most adults have been infected with EBY. Many studies have indicated that antibodies against specific EEV antigens, particularly IgA antibodies, can be predictive or prognostic of EBV-associated malignancies, such as NPC. We hypothesized that healthy individuals from families with a history of multiple members affected with NPC (who therefore might be genetically susceptible to NPC themselves) might have an EBV antibody profile that is distinct from that seen in healthy individuals from the community at large. To explore this possibility and examine determinants of anti-EBV antibody levels in healthy, high-risk individuals, we evaluated data from 2 parallel studies of NPC in Taiwan, which included 1,229 healthy members of families in which 2 or more individuals were affected with NPC and 320 controls from the community at large. Blood collected from participants was tested for IgA antibodies against EBV VCA and EBNA-1 and for neutralizing antibodies against EBV DNase using standard assays. We observed evidence of familial aggregation of EBV seroreactivity among individuals from high-risk, multiplex NPC families. Anti-VCA IgA and anti-EBNA-1 IgA antibody seroprevalence in unaffected family members of NPC cases was 5-6 times higher than in members of the community (p < 0.01). This elevated seroprevalence among unaffected individuals from high-risk families was observed regardless of the relationship of the unaffected individual to the closest affected relative (siblings, parents, children or spouses). No sociodemographic or environmental factors examined were found to strongly and consistently correlate with elevated seroprevalence, but patterns emerged of increasing sero-prevalence among older individuals and among females. Unaffected individuals from high-risk NPC families have elevated anti-EBV IgA antibody titers. The etiologic and clinical implications of this finding remain to be established.

Original languageEnglish
Pages (from-to)117-123
Number of pages7
JournalInternational Journal of Cancer
Volume111
Issue number1
DOIs
StatePublished - 08 2004
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Epstein-Barr virus
  • Nasopharyngeal carcinoma
  • Susceptibility

Fingerprint

Dive into the research topics of 'Epstein-Barr virus seroreactivity among unaffected individuals within high-risk nasopharyngeal carcinoma families in Taiwan'. Together they form a unique fingerprint.

Cite this